Stockholders’ Equity (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Nov. 30, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Repurchase of shares, value			$ 2,482,286
Common stock, shares authorized		25,000,000		25,000,000
Common stock, shares issued		10,857,040		10,857,040
Common stock, shares outstanding		10,857,040		10,857,040
Weighted average exercise price		$ 6.28		$ 6.46
Stock-based compensation		$ 333,530	267,004
Number of shares, granted		70,000
Number of shares, cancelled or expired		12,545
Share-Based Payment Arrangement, Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock-based compensation		$ 334,000	$ 267,000
Number of shares, exercised			0
Number of shares, granted			0
Number of shares, cancelled or expired			0
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Repurchase of shares			353,667
Repurchase of shares, value			$ 36
Issuance of stock			95,779
Proceeds from warrants exercise			$ 300,000
Exercise price			$ 3.13
Weighted average exercise price		$ 6.01
Number of shares, exercised		790,115
Common Stock [Member] | Director [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Repurchase of shares			353,667
Repurchase of shares, value			$ 2,482,000
Common Stock [Member] | Director [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Repurchase of shares	7,000,000
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase shares of common stock		177,998	95,779
Weighted average exercise price		$ 9.27
Warrant [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expiration date of warrants		Jun. 10, 2025
Warrant [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expiration date of warrants		Mar. 07, 2024